Skip to main content
IONS logo

IONS

Ionis Pharmaceuticals, Inc.

$26.61

2.26%

Trade Ideas Performance

Latest Closed Trade Idea

$26.61

2.26%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

6

Social

72

About

Events of Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals, Inc.'s stock price has been significantly impacted over the past six months, plummeting from 52-week highs of $86.74 in early July 2026. On July 9, 2026, the stock dropped 17.6%, losing over $3.3 billion in market capitalization, primarily due to the Phase 3 CARDIO-TTRansform trial for eplontersen failing to meet its primary efficacy endpoint, attributed to a high percentage of patients already on stabilizer treatment. Further declines were caused by broader clinical and competitive disappointments, including diminished blockbuster ambitions for WAINUA and TRYNGOLZA, and failed Phase 2/3 trials with partners like AstraZeneca, Roche, and Biogen. Overall, the stock has declined approximately 46% over the past 52 weeks, with its market capitalization compressing from around $13 billion to approximately $6.7 billion, reflecting investor caution regarding near-term launch execution and reimbursement hurdles versus long-term pipeline potential.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)